Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers from Uppsala University report details of new studies and findings in the area of immunization
May 14th, 2008
Researchers in Uppsala, Sweden conducted a study "To evaluate compliance, serologic response and the cost-benefit of a low-dose intradermal hepatitis B vaccination programme, followed by intramuscular boosters in non-responders. The study comprised a retrospective survey of 1521 health-care workers and 968 students." "Response was defined as hepatitis B antibody titres >= 10 IU/L. Non-response included vaccinees with undetectable antibodies and a hypo-response if antibodies were detectable. Overall, 2145/2489 (86%) subjects completed the intradermal series, whereof 1840/2489 (74%) complied with the serological check-up. Response was achieved in 1517/1840 (82.5%),...
Source: Vaccine Weekly (2008-05-14)
|
